StockMarketWire.com - Venture capital company Arix Bioscience swung to a half-yearly loss as net asset value per share fell 14.5% thanks to a slump in Autolus' share price.

For the period ended 30 June 2019, the company reported a pre-tax loss of £44.8m, compared with a profit of £29.3m a year earlier.

Net asset value fell to £231.8m from £270.2m last year, and NAV per share declined 14.5% to 171 pence.

'The reduction in NAV for the first half of 2019 was principally due to a reduction in the share price of our largest quoted company, Autolus,' the company said.


At 9:48am: [LON:ARIX] Arix Bioscience Plc share price was 0p at 109.5p



Story provided by StockMarketWire.com